TY - JOUR
T1 - Perceptions of Heated Tobacco Products (HTPs) Versus Cigarettes and e-Cigarettes in Relation to Likelihood of Trying HTPs or Suggesting HTPs to Those who Smoke Cigarettes
AU - Duan, Zongshuan
AU - Berg, Carla J.
AU - Bar-Zeev, Yael
AU - Abroms, Lorien C.
AU - Wang, Yan
AU - Khayat, Amal
AU - Cui, Yuxian
AU - LoParco, Cassidy R.
AU - Levine, Hagai
N1 - Publisher Copyright:
© The Author(s) 2024. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved.
PY - 2024/10/1
Y1 - 2024/10/1
N2 - Introduction: Heated tobacco products (HTPs), like IQOS, are marketed as innovative, stylish, harm-reduction products distinct from cigarettes and e-cigarettes. Research is needed to better understand how adults who are newly introduced to HTPs perceive them relative to cigarettes and e-cigarettes, and the impact of these perceptions on use outcomes. Aims and Methods: We analyzed 2021 cross-sectional survey data from 1914 adults who never used HTPs from the United States and Israel, two countries where IQOS has unique histories and markets. Exploratory factor analysis examined perceptions of HTPs (vs. cigarettes and e-cigarettes) across 12 perception measures (eg, innovative, trendy, harmful, addictive). Multivariable linear regression examined these factors in relation to self-reported likelihood to: (1) “try HTPs in the next year” (1 = not–7 = extremely) and (2) “suggest IQOS to a friend who smokes cigarettes” (1 = not–5 = very), controlling for demographics and past-month cigarette and e-cigarette use (10.1% dual use, 15.4% cigarette-only, 5.7% e-cigarette-only, 68.8% neither). Results: Four factors were identified: HTPs’ health and utility (“health-utility”) and design and appeal (“design-appeal”) versus cigarettes and versus e-cigarettes, separately. More favorable perceptions of HTP versus e-cigarette design-appeal (B = 0.30, 95% CI = 0.18, 0.41) were associated with greater likelihood to try HTPs. More favorable perceptions of HTP versus cigarette design-appeal (B = 0.38, 95% CI = 0.26, 0.51) and health-utility (B = 0.25, 95% CI = 0.13, 0.36), and HTP versus e-cigarette design-appeal (B = 0.32, 95% CI = 0.20, 0.45) were associated with greater likelihood to suggest HTPs to smokers. Conclusions: Monitoring perceptions of HTPs versus cigarettes and e-cigarettes is critical given the role of such perceptions in HTP use and their population-level impact. Implications: This study examined the relationship of perceptions of HTPs relative to cigarettes and e-cigarettes, with regard to adults’ self-reported likelihood to use HTP or to suggest HTPs to those who smoke cigarettes. Favorable perceptions of HTPs’ design and appeal versus e-cigarettes correlated with greater likelihood to try HTPs. Favorable perceptions of HTPs’ design and appeal, as well as health and utility, versus cigarettes and e-cigarettes correlated with greater likelihood to suggest HTPs to those who smoke. Findings underscore the need for ongoing surveillance of HTP marketing and consumer perceptions to inform regulatory efforts and estimate the population-level impact of HTPs and other tobacco products.
AB - Introduction: Heated tobacco products (HTPs), like IQOS, are marketed as innovative, stylish, harm-reduction products distinct from cigarettes and e-cigarettes. Research is needed to better understand how adults who are newly introduced to HTPs perceive them relative to cigarettes and e-cigarettes, and the impact of these perceptions on use outcomes. Aims and Methods: We analyzed 2021 cross-sectional survey data from 1914 adults who never used HTPs from the United States and Israel, two countries where IQOS has unique histories and markets. Exploratory factor analysis examined perceptions of HTPs (vs. cigarettes and e-cigarettes) across 12 perception measures (eg, innovative, trendy, harmful, addictive). Multivariable linear regression examined these factors in relation to self-reported likelihood to: (1) “try HTPs in the next year” (1 = not–7 = extremely) and (2) “suggest IQOS to a friend who smokes cigarettes” (1 = not–5 = very), controlling for demographics and past-month cigarette and e-cigarette use (10.1% dual use, 15.4% cigarette-only, 5.7% e-cigarette-only, 68.8% neither). Results: Four factors were identified: HTPs’ health and utility (“health-utility”) and design and appeal (“design-appeal”) versus cigarettes and versus e-cigarettes, separately. More favorable perceptions of HTP versus e-cigarette design-appeal (B = 0.30, 95% CI = 0.18, 0.41) were associated with greater likelihood to try HTPs. More favorable perceptions of HTP versus cigarette design-appeal (B = 0.38, 95% CI = 0.26, 0.51) and health-utility (B = 0.25, 95% CI = 0.13, 0.36), and HTP versus e-cigarette design-appeal (B = 0.32, 95% CI = 0.20, 0.45) were associated with greater likelihood to suggest HTPs to smokers. Conclusions: Monitoring perceptions of HTPs versus cigarettes and e-cigarettes is critical given the role of such perceptions in HTP use and their population-level impact. Implications: This study examined the relationship of perceptions of HTPs relative to cigarettes and e-cigarettes, with regard to adults’ self-reported likelihood to use HTP or to suggest HTPs to those who smoke cigarettes. Favorable perceptions of HTPs’ design and appeal versus e-cigarettes correlated with greater likelihood to try HTPs. Favorable perceptions of HTPs’ design and appeal, as well as health and utility, versus cigarettes and e-cigarettes correlated with greater likelihood to suggest HTPs to those who smoke. Findings underscore the need for ongoing surveillance of HTP marketing and consumer perceptions to inform regulatory efforts and estimate the population-level impact of HTPs and other tobacco products.
UR - http://www.scopus.com/inward/record.url?scp=85204819674&partnerID=8YFLogxK
U2 - 10.1093/ntr/ntae093
DO - 10.1093/ntr/ntae093
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 38666732
AN - SCOPUS:85204819674
SN - 1462-2203
VL - 26
SP - 1394
EP - 1403
JO - Nicotine and Tobacco Research
JF - Nicotine and Tobacco Research
IS - 10
ER -